Based on the board of directors’ approval, stock acquisition rights are allocated to directors, executive officers, and employees. Eligible individuals total 4 directors, 13 executive officers, and 116 employees. Total allocation: 15,710 units; underlying shares: 1,571,000 common shares; grant per unit: 100 shares; exercise price: 6,289 yen; exercise period: from October 1, 2028 to September 29, 2033.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4063","jir_company_name":"Shin-Etsu Chemical Company, Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-15","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4063-20260915-03.pdf","jir_short_summary":"Based on the board of directors' approval, stock acquisition rights are allocated to directors, executive officers, and employees. Eligible individuals total 4 directors, 13 executive officers, and 116 employees. Total allocation: 15,710 units; underlying shares: 1,571,000 common shares; grant per unit: 100 shares; exercise price: 6,289 yen; exercise period: from October 1, 2028 to September 29, 2033.","jir_summary":"### Purpose and recipients of stock options\nThis is allocated to boost motivation and morale for fulfilling duties and improving performance, by granting stock acquisition rights to directors, executive officers, and employees. Allocation date: September 30, 2026. Eligible recipients include 4 internal directors (excluding outside directors), 13 executive officers, and 116 employees.\n\n### Conditions and adjustments of stock options\nEach option unit grants 100 shares. Total units: 15,710. Exercise price is 6,289 yen, with provisions for rounding adjustments, adjustments for stock splits or consolidations, and measures in the event of a market price decline. Exercise period: October 1, 2028 to September 29, 2033.","jir_financial_highlights":"Total number of stock acquisition rights: 15,710 units (unknown)\nGranted shares: 1,571,000 shares (unknown)\nExercise price: 6,289 yen (unknown)","jir_category":"","jir_hashtags":"#Shin-EtsuChemical, #StockOptionAllocation, #StockOptions","jir_key_figures":"Total number of stock acquisition rights: 15,710 units\nGranted shares: 1,571,000 shares\nExercise price: 6,289 yen","jir_meta_title":"\u3010Shin-Etsu Chemical\u3011Stock Option Allocation Notice\uff5cSeptember 2026","jir_meta_description":"Shin-Etsu Chemical allocates stock acquisition rights to directors, executive officers, and employees. Total 15,710 units; granted shares 1,571,000; exercise price 6,289 yen; exercise period from 2028-10-01 to 2033-09-29.","jir_og_title":"Shin-Etsu Chemical | Stock Option Allocation Notice","jir_og_description":"Announcement of stock option allocation. Eligible recipients are directors, executive officers, and employees; total units are 15,710. Exercise period is 2028\u20132033.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6847,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-114175","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n